• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients.

作者信息

Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M

机构信息

AdRes HE&OR, Turin, Italy.

HE OR Unit - Bristol-Myers Squibb S. r. l., Rome, Italy.

出版信息

Value Health. 2014 Nov;17(7):A486-7. doi: 10.1016/j.jval.2014.08.1427. Epub 2014 Oct 26.

DOI:10.1016/j.jval.2014.08.1427
PMID:27201435
Abstract
摘要

相似文献

1
Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients.
Value Health. 2014 Nov;17(7):A486-7. doi: 10.1016/j.jval.2014.08.1427. Epub 2014 Oct 26.
2
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.阿哌沙班与华法林在伴有心房颤动和心脏瓣膜病患者中的比较：来自心房颤动患者阿哌沙班减少卒中和其他血栓栓塞事件（ARISTOTLE）试验的结果。
Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.
3
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.阿哌沙班与其他新型口服抗凝药预防心房颤动卒中的成本效益比较。
Clin Ther. 2014 Feb 1;36(2):192-210.e20. doi: 10.1016/j.clinthera.2013.12.011. Epub 2014 Feb 6.
4
Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients.阿哌沙班与其他新型口服抗凝药预防意大利非瓣膜性心房颤动患者卒中的预算影响分析
Value Health. 2014 Nov;17(7):A479. doi: 10.1016/j.jval.2014.08.1383. Epub 2014 Oct 26.
5
Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients.阿哌沙班与其他新型口服抗凝药用于意大利非瓣膜性心房颤动患者预防卒中的成本效益分析
Value Health. 2014 Nov;17(7):A487-8. doi: 10.1016/j.jval.2014.08.1432. Epub 2014 Oct 26.
6
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.达比加群、利伐沙班和阿哌沙班治疗心房颤动的间接比较。
Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28.
7
Apixaban and atrial fibrillation: no clear advantage.
Prescrire Int. 2014 Feb;23(146):33-6.
8
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.新型口服抗凝药物在房颤卒中预防中的应用：重点关注阿哌沙班。
Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7.
9
Role of new drugs for management of atrial fibrillation.新型药物在心房颤动治疗中的作用。
Ann Pharmacother. 2012 Dec;46(12):1656-70. doi: 10.1345/aph.1R155. Epub 2012 Dec 18.
10
Application of randomized clinical trial data to actual practice: apixaban therapy for reduction of stroke risk in non-valvular atrial fibrillation patients.随机临床试验数据在实际中的应用：非瓣膜性心房颤动患者中应用阿哌沙班进行卒中预防治疗。
Curr Med Res Opin. 2013 Oct;29(10):1253-61. doi: 10.1185/03007995.2013.818967. Epub 2013 Jul 18.

引用本文的文献

1
Analysis of the Introduction in Clinical Practice of New Oral Anticoagulants in Local Health Agency BT: Translation of the Clinical Trial Data to a Local Health Care Area.地方卫生局BT新口服抗凝剂临床应用的引入分析：临床试验数据向地方医疗保健领域的转化
Pharmaceutics. 2021 Feb 11;13(2):252. doi: 10.3390/pharmaceutics13020252.
2
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.阿哌沙班用于非瓣膜性心房颤动卒中预防的成本效益的系统文献综述
Cardiol Ther. 2016 Dec;5(2):171-186. doi: 10.1007/s40119-016-0066-2. Epub 2016 Jul 25.